The FDA and CTTI are currently accepting applications from patient advocates interested in becoming members of the Patient Engagement Collaborative (PEC). The PEC is an ongoing, collaborative forum that brings the patient community and regulators together to discuss ways to increase patient engagement in medical product development and regulatory discussions at the FDA.

Applicants will be selected based on their ability to meaningfully contribute to the PEC, represent and express the patient voice for their constituency, work in a constructive manner with involved stakeholders, and understand and navigate the clinical research ecosystem.

Successful applicants will include:

• Patients who have personal disease experience
• Caregivers who support patients, such as a family member or friend, and who have personal disease experience through this caregiver role
• Representatives from patient groups who, through their role in the patient group, have direct or indirect disease experience

PEC members will be expected to participate in working meetings two to four times per year, either in-person (in the Washington D.C. area) or virtually. Given the ongoing COVID-19 pandemic, meetings will be conducted virtually and may resume in-person when it is safe to do so. Additional meetings may be organized as needed, and currently include monthly, one-hour teleconferences.

Interested applicants are encouraged to complete and submit the online form no later than 11:59 p.m. ET on August 23, 2021. Those who are unable to submit an application electronically are encouraged to call the FDA’s Office of Patient Affairs at 301-796-8460 to arrange for a mail submission.

Please review the related Federal Register notice for important information about the application process.